Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday’s Mid-Day Session – Acer Therapeutics (NASDAQ:ACER), Aclarion (NASDAQ:ACON)

Small Cap Education By , March 17, 2023

Gainers

  • Enzo Biochem, Inc. ENZ gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.

  • Histogen Inc. HSTO climbed 60% to $1.39 after the company announced issuance of a US patent covering CTS-2090 methods of use.

  • QualTek Services Inc. QTEK gained 56.4% to $0.4379. QualTek secured new money financing.

  • AirNet Technology Inc. ANTE climbed 38.3% to $1.12.

  • Maxpro Capital Acquisition Corp. JMAC gained 38% to $13.66.

  • Lixiang Education Holding Co., Ltd. LXEH jumped 28% to $1.25.

  • Traeger, Inc. COOK gained 24% to $3.7415 after the company announced better-than-expected Q4 results.

  • AppTech Payments Corp. APCX jumped 22.8% to $1.5350.

  • Aclarion, Inc. ACON gained 20% to $0.83.

  • Berkshire Grey, Inc. BGRY climbed 18.3% to $1.16.

  • Meihua International Medical Technologies Co., Ltd. MHUA jumped 18% to $15.98

  • Paranovus Entertainment Technology Ltd. PAVS gained 18% to $4.63.

  • Boqii Holding Limited BQ gained 15.7% to $1.10.

  • Orla Mining Ltd. ORLA climbed 13.7% to $4.55 after the company reported Q4 EPS results were higher year over year.

  • Riot Platforms, Inc. RIOT gained 10.3% to $7.78.

  • Coinbase Global, Inc. COIN surged 9.4% to $74.15.

  • XPeng Inc. XPEV gained 8.2% to $9.02 after the company reported a fourth-quarter FY22 sales decline of 39.9% year-on-year, to RMB5.14 billion ($745.28 million), missing the consensus of $834.05 million.

  • FedEx Corporation FDX rose 8% to $220.32 after the company reported better-than-expected Q3 EPS and raised its FY23 outlook.

  • Orchestra BioMed Holdings, Inc. OBIO jumped 7.4% to $13.57.

  • Baidu, Inc. BIDU gained 6.2% to $146.74 after the company announced it has been granted the first-ever permits to provide fully driverless ride-hailing service in the Chinese capital Beijing.

Losers

  • Lifecore Biomedical, Inc. LFCR shares declined 61.6% to $1.9616 after the company reported worse-than-expected Q2 financial results.

  • Diebold Nixdorf, Incorporated DBD dropped 53.5% to $1.07. Wedbush reiterated Diebold Nixdorf with an Outperform and maintained a $5 price target.

  • Acer Therapeutics Inc. ACER fell 46.4% to $0.8313 after the company announced its Phase 2a trial data showing ACER-801 was safe and well-tolerated but did not achieve statistical significance when evaluating the ability to decrease the frequency or severity of hot flashes in postmenopausal women.

  • Pear Therapeutics, Inc. PEAR declined 44% to $0.33. Pear Therapeutics announced process exploring strategic alternatives.

  • Blend Labs, Inc. BLND dropped 36.5% to $0.9338 after the company reported worse-than-expected Q4 adjusted EPS and sales results.

  • Nexters Inc. GDEV shares fell 35.7% to $3.60 after the company issued Q4 update.

  • Loyalty Ventures Inc. LYLT dropped 26.8% to $0.1061.

  • First Republic Bank FRC dropped 26.2% to $25.23 after the bank announced a deal for $30 billion in deposits from major banks and said it has decided to suspend its dividend.

  • Panbela Therapeutics, Inc. PBLA dropped 23.5% to $0.5050 after the company reported worse-than-expected Q4 EPS results.

  • Purple Innovation, Inc. PRPL fell 21.6% to $2.5815 after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 revenue guidance below analyst estimates.

  • Sarepta Therapeutics, Inc. SRPT dropped 19.9% to $119.83 after the company said that that FDA has decided to hold a public advisory committee meeting on its SRP 9001 BLA.

  • Casa Systems, Inc. CASA fell 19.8% to $1.3950.

  • Reliance Global Group, Inc. RELI fell 19.3% to $3.1299.

  • Montauk Renewables, Inc. MNTK declined 19% to $7.70 after the company reported full year 2022 results.

  • RedHill Biopharma Ltd. RDHL fell 19% to $0.1457. RedHill Biopharma announced plan to implement ADS ratio change from a 1 ADS-for-10 ordinary shares ratio to a 1 ADS-for-400 ordinary share ratio (1-for-40) on or about March 23, 2023.

  • Groupon, Inc. GRPN fell 19% to $3.97 after the company reported worse-than-expected Q4 sales results.

  • Western Alliance Bancorporation WAL dropped 17.6% to $30.34. Shares of several companies in the broader financial space traded lower on continued downward momentum in the sector amid volatility and stability concerns following multiple bank failures.

  • Impac Mortgage Holdings, Inc. IMH fell 17.5% to $0.24 after posting a wider quarterly loss.

  • Pharming Group N.V. PHAR fell 17% to $9.94 following Q4 results.

  • Semantix, Inc. STIX dropped 16.8% to $ 3.7250.

  • CareMax, Inc. CMAX fell 16.6% to $3.0350. CareMax said it sees FY22 revenue of $631.1 million.

  • Karooooo Ltd. KARO dipped 15.8% to $22.00.

  • OncoCyte Corporation OCX fell 15% to $0.2574.

  • Aspen Aerogels, Inc. ASPN dropped 14.7% to $6.67.

  • Dermata Therapeutics, Inc. DRMA fell 14% to $1.90.

  • PacWest Bancorp PACW fell 13.3% to $ 9.93.

  • Sunnova Energy International Inc. NOVA fell 14.4% to $12.59.

  • Emergent BioSolutions Inc. EBS dropped 12.8% to $8.41 after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $23 to $9.

  • Cutera, Inc. CUTR fell 11.1% to $24.75.

  • Sunrun Inc. RUN dropped 10% to $17.10.

  • Metropolitan Bank Holding Corp. MCB fell 10% to $35.81.

  • SL Green Realty Corp. SLG dropped 9.6% to $23.77.

  • Despegar.com, Corp. DESP fell 9.2% to $5.01. Despegar.com recently posted downbeat quarterly results.

  • Design Therapeutics, Inc. DSGN dropped 8.8% to $6.41.

Now Read This: Top 5 Tech Stocks Which You’ll Regret Missing This Quarter

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.



Source link